Characterization of Vibrio cholerae O1 isolates responsible for cholera outbreaks in Kenya between 1975 and 2017.


Journal

Microbiology and immunology
ISSN: 1348-0421
Titre abrégé: Microbiol Immunol
Pays: Australia
ID NLM: 7703966

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 29 01 2019
revised: 12 06 2019
accepted: 10 07 2019
pubmed: 14 8 2019
medline: 16 10 2019
entrez: 14 8 2019
Statut: ppublish

Résumé

Kenya is endemic for cholera with different waves of outbreaks having been documented since 1971. In recent years, new variants of Vibrio cholerae O1 have emerged and have replaced most of the traditional El Tor biotype globally. These strains also appear to have increased virulence, and it is important to describe and document their phenotypic and genotypic traits. This study characterized 146 V. cholerae O1 isolates from cholera outbreaks that occurred in Kenya between 1975 and 2017. Our study reports that the 1975-1984 strains had typical classical or El Tor biotype characters. New variants of V. cholerae O1 having traits of both classical and El Tor biotypes were observed from 2007 with all strains isolated between 2015 and 2017 being sensitive to polymyxin B and carrying both classical and El Tor type ctxB. All strains were resistant to Phage IV and harbored rstR, rtxC, hlyA, rtxA and tcpA genes specific for El Tor biotype indicating that the strains had an El Tor backbone. Pulsed field gel electrophoresis (PFGE) genotyping differentiated the isolates into 14 pulsotypes. The clustering also corresponded with the year of isolation signifying that the cholera outbreaks occurred as separate waves of different genetic fingerprints exhibiting different genotypic and phenotypic characteristics. The emergence and prevalence of V. cholerae O1 strains carrying El Tor type and classical type ctxB in Kenya are reported. These strains have replaced the typical El Tor biotype in Kenya and are potentially more virulent and easily transmitted within the population.

Identifiants

pubmed: 31407393
doi: 10.1111/1348-0421.12731
doi:

Substances chimiques

Bacterial Proteins 0
DNA, Bacterial 0
Virulence Factors 0
Cholera Toxin 9012-63-9
Polymyxin B J2VZ07J96K

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

350-358

Subventions

Organisme : JSPS RONPAKU (Dissertation PhD) Program

Informations de copyright

© 2019 The Societies and John Wiley & Sons Australia, Ltd.

Auteurs

Martin Bundi (M)

Department of Bacteriology, NUITM-KEMRI Project, Kenya Research Station, Institute of Tropical Medicine, Nagasaki University, Nairobi, Kenya.
Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.
Department of Biosafety Training and Accreditation, National Biosafety Authority, Nairobi, Kenya.

Mohammad Monir Shah (MM)

Department of Bacteriology, NUITM-KEMRI Project, Kenya Research Station, Institute of Tropical Medicine, Nagasaki University, Nairobi, Kenya.
Department of Pediatric Infectious Diseases, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.

Eric Odoyo (E)

Department of Bacteriology, NUITM-KEMRI Project, Kenya Research Station, Institute of Tropical Medicine, Nagasaki University, Nairobi, Kenya.

Cyrus Kathiiko (C)

Department of Bacteriology, NUITM-KEMRI Project, Kenya Research Station, Institute of Tropical Medicine, Nagasaki University, Nairobi, Kenya.

Ernest Wandera (E)

Department of Bacteriology, NUITM-KEMRI Project, Kenya Research Station, Institute of Tropical Medicine, Nagasaki University, Nairobi, Kenya.

Gabriel Miring'u (G)

Department of Bacteriology, NUITM-KEMRI Project, Kenya Research Station, Institute of Tropical Medicine, Nagasaki University, Nairobi, Kenya.

Sora Guyo (S)

Department of Bacteriology, NUITM-KEMRI Project, Kenya Research Station, Institute of Tropical Medicine, Nagasaki University, Nairobi, Kenya.

Daniel Langat (D)

Disease Surveillance and Response Unit, Ministry of Health, Nairobi, Kenya.

Kouichi Morita (K)

Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.
Department of Virology, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.

Yoshio Ichinose (Y)

Department of Bacteriology, NUITM-KEMRI Project, Kenya Research Station, Institute of Tropical Medicine, Nagasaki University, Nairobi, Kenya.
Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH